Alex Shlyankevich

Alex has 25 years of leadership experience at a number of start ups and established companies, including Cardinal Health, Biovail, CombinatoRx, Avecia and Moderna. In his current role, Alex is President of MH Biomedical Investments and serves on the boards of NuPulseCV and Felicitex Therapeutics.